Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology-Reference-Cited by-同舟云学术

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Published:2016-03-20 Issue:9 Volume:34 Page:987-1011
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Dizon Don S.¹,Krilov Lada¹,Cohen Ezra¹,Gangadhar Tara¹,Ganz Patricia A.¹,Hensing Thomas A.¹,Hunger Stephen¹,Krishnamurthi Smitha S.¹,Lassman Andrew B.¹,Markham Merry Jennifer¹,Mayer Erica¹,Neuss Michael¹,Pal Sumanta Kumar¹,Richardson Lisa C.¹,Schilsky Richard¹,Schwartz Gary K.¹,Spriggs David R.¹,Villalona-Calero Miguel Angel¹,Villani Gina¹,Masters Gregory¹

Affiliation:

1. Don S. Dizon, Massachusetts General Hospital, Boston; Erica Mayer, Dana-Farber Cancer Institute, Boston, MA; Lada Krilov and Richard Schilsky, American Society of Clinical Oncology, Alexandria, VA; Ezra Cohen, University of California San Diego, San Diego; Patricia A. Ganz, University of California Los Angeles, Los Angeles; Sumanta Kumar Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Tara Gangadhar, University of Pennsylvania; Stephen Hunger, Children's Hospital Center of Philadelphia,...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2015.65.8427

Reference51 articles.

1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

2. Invasive Cancer Incidence and Survival — United States, 2012

3. Pembrolizumab versus Ipilimumab in Advanced Melanoma

4. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

5. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence;Medicine;2023-12-01

2. Triazole Moieties as Potent Drug Molecules: Synthetic Approaches and Application as Promising Candidates as Anticancer Agents (A Review);Russian Journal of Bioorganic Chemistry;2023-12

3. Роль микробиоты в канцерогенезе;Malignant tumours;2023-11-23

4. “Post-renal acute kidney injury in patients with cancer: Clinical presentation and kidney and patient outcomes”;Journal of Onco-Nephrology;2023-08-08

5. Clinical features and outcomes of patients admitted to the ICU for Cyclophosphamide-associated cardiac toxicity: a retrospective cohort;Supportive Care in Cancer;2023-07-18